Losing interest in sex during menopause is extremely common, and it’s driven by real physiological changes, not just “being in your head.” The good news: there are several effective strategies, from hormonal options to physical therapy to targeted lifestyle changes, that can meaningfully restore desire. What works best depends on what’s driving your particular experience.
Why Libido Drops During Menopause
Two hormonal shifts happen simultaneously during menopause, and both affect desire. The more familiar one is the steep decline in estrogen as follicular function stops. But the less discussed change may matter just as much: your testosterone levels fall significantly. The adrenal glands, which produce testosterone precursors, slow their output so dramatically that the ovaries can’t compensate, resulting in a net decline in circulating testosterone.
Reduced testosterone is linked to lower sexual motivation, diminished arousal, and decreased lubrication. Meanwhile, falling estrogen thins the vaginal lining, reduces blood flow to the area, and can make penetration painful. When sex hurts or your body simply doesn’t respond the way it used to, desire naturally fades further. Understanding that both hormones play a role is important because treatments that only address estrogen often leave libido unchanged.
Address Pain and Vaginal Comfort First
About 60% of postmenopausal women with vulvovaginal symptoms report pain with vaginal penetration as their primary complaint. If sex is uncomfortable, no amount of desire-boosting treatment will feel like enough. This is often the most productive place to start.
Interestingly, a large randomized trial of 302 women found that low-dose vaginal estrogen tablets, vaginal moisturizers, and placebo gel all produced similar reductions in symptom severity over 12 weeks. None outperformed the others statistically. That doesn’t mean these products are useless. All three groups improved, which suggests that consistent use of any vaginal moisturizer or lubricant, combined with regular application and the expectation of improvement, can reduce pain meaningfully. If over-the-counter moisturizers aren’t enough, vaginal estrogen remains an option worth discussing with your provider, particularly for more severe atrophy.
Pelvic Floor Training Improves Arousal
Pelvic floor muscle training (sometimes done with a specialized physical therapist) has a surprisingly strong effect on sexual function after menopause. A meta-analysis found significant improvements in arousal among postmenopausal women who did structured pelvic floor exercises. The benefits go beyond just strengthening muscles. Training improves tissue elasticity, blood flow, and lubrication in the vaginal area, directly counteracting the effects of estrogen loss. It also reduces pain during sex by improving the flexibility and control of pelvic muscles.
Perhaps just as importantly, women who do pelvic floor work report feeling more connected to their bodies during sexual activity. Greater awareness and control of the pelvic floor can shift the experience of sex from something that feels unpredictable or uncomfortable to something that feels more within your control. You can start with Kegel exercises at home, but working with a pelvic floor physical therapist gives you feedback on whether you’re engaging the right muscles.
Testosterone Therapy for Desire
Because falling testosterone is a primary driver of low desire, adding it back can be effective. Testosterone is not officially approved for women in most countries, but it’s widely prescribed off-label as a cream or gel at about one-tenth the male dose. A typical starting dose is around 5 mg per day of a 1% testosterone cream or gel.
The British Menopause Society recommends that testosterone be added as a supplement to existing hormone therapy, not used alone. Before starting, your provider should confirm you’re already adequately treated with estrogen (meaning hot flashes and night sweats are under control). They’ll also check your free androgen index, a calculation based on your total testosterone and a binding protein called SHBG. If your index is below 1%, you’re a good candidate for a trial. Once on treatment, levels are checked at 3 to 6 weeks, with the goal of keeping the free androgen index below 5%. Clinical improvement in symptoms matters more than hitting a specific number.
One important detail: if you take estrogen by mouth rather than through the skin, it raises SHBG levels, which binds up your free testosterone and can actually worsen low desire. Transdermal estrogen (patches, gels, or sprays) is preferred for women with libido concerns because it avoids this effect.
Medications That Target Desire Directly
Two prescription medications are approved in the U.S. specifically for low sexual desire in women. Flibanserin is a daily bedtime pill that works on serotonin pathways in the brain. Bremelanotide is a self-administered injection taken before sexual activity that acts on different brain receptors involved in arousal.
Flibanserin has shown measurable improvements in desire, satisfying sexual events per month, and sexual distress scores in postmenopausal women. However, the side effects are notable: roughly 16% of users experience drowsiness, about 7% report fatigue, 6% dizziness, and 6% nausea. These effects are generally mild, and serious adverse events are no more common than with placebo, but the overall benefit-to-side-effect balance is modest. These medications work best for women whose low desire causes significant personal distress and who haven’t responded to other approaches.
Sleep Is More Connected to Desire Than You Think
Poor sleep and low libido are deeply intertwined during menopause, and this connection is backed by large-scale data. A study of over 53,000 postmenopausal women found that those sleeping five hours or less per night had 12% lower odds of sexual satisfaction compared to women sleeping seven to eight hours. Women with insomnia symptoms were significantly less sexually active, less satisfied, and scored lower on every measure of sexual function. These associations held up even after accounting for age, depression, relationship status, and other health factors.
Separately, 64% of postmenopausal women not using hormone therapy reported diminished libido, and poor sleep was a key associated factor. If you’re dealing with night sweats, insomnia, or fragmented sleep, treating those issues may do more for your desire than any supplement. Prioritizing consistent sleep timing, keeping your bedroom cool, and addressing hot flashes with your provider are practical starting points that can have downstream effects on your sex life.
Therapy Designed for Menopause-Related Sexual Concerns
A cognitive behavioral therapy protocol developed specifically for sexual concerns during perimenopause and postmenopause showed significant improvements across the board in a pilot trial. After just four individual sessions, participants experienced meaningful gains in desire, arousal, and satisfaction, along with reduced sexual distress, less anxiety and depression, better body image, and improved relationship satisfaction. No changes occurred during the pre-treatment waiting period, suggesting the therapy itself drove the improvements.
This approach works by addressing the thoughts and behaviors that accumulate around sex during menopause: avoidance patterns, negative body image, anxiety about pain, and shifts in how you see yourself as a sexual person. These psychological layers often pile on top of the hormonal changes and can independently suppress desire. Even if you also pursue hormonal or medical treatments, working through these patterns can amplify their effects.
What About Maca Root?
Maca root is one of the most popular supplements marketed for female libido, but the evidence is mixed. In a double-blind, placebo-controlled trial, maca did not significantly outperform placebo overall for sexual function scores. However, when researchers looked specifically at postmenopausal women (a small subgroup), the results were more promising: 57% of postmenopausal women on maca achieved meaningful improvement on one sexual function scale compared to 20% on placebo, and maca specifically improved orgasm in this group. These numbers come from a very small sample, so the confidence intervals are wide, but maca appears to be one supplement where postmenopausal women may see more benefit than younger women. It’s generally well-tolerated, though it shouldn’t be expected to substitute for proven hormonal or therapeutic options.
Putting It Together
The most effective approach typically layers several strategies rather than relying on a single fix. Start with the basics: treat vaginal discomfort so sex isn’t painful, address sleep problems that may be silently suppressing your desire, and consider pelvic floor training to rebuild physical responsiveness. If desire remains low after those foundations are in place, testosterone therapy added to transdermal estrogen is the intervention with the strongest evidence for restoring motivation and arousal. Therapy targeting menopause-specific sexual concerns can address the psychological dimension that hormones alone won’t reach. Prescription medications for desire exist but work best as a later option when other approaches haven’t been enough.